|
The Low Energy Neurofeedback System (LENS)
LENS
is an EEG biofeedback system being used in clinical applications and research in
the treatment of central nervous system functioning. It is unique in the field
of neurofeedback in that instead of only displaying information on a computer
screen to assist the patient in conditioning healthier brainwave patterns, the
LENS uses tiny electromagnetic signals as a carrier wave for the feedback to
assist in reorganizing brainwave activity.
The LENS works by continuously
monitoring EEG activity and then uses these readings to determine the frequency
of very small electromagnetic fields that are “offset” several cycles per second
(hertz) faster than the patient’s dominant brainwave. This feedback stimulus
input is then delivered down electrode wires at generally 7 or fewer electrode
sites in the course of a treatment session, for only one second per site. This
input is much weaker than what the brain receives from holding a cell phone to
one’s ear.
How can
non-perceivable feedback to the brain that is of such minimal magnitude still be
influential? While the mechanism of how this happens remains to be determined,
it is clear from both the documented effects of these feedback signals on the
amplitudes and variability of brainwaves, that (1) this feedback is being
processed by the brain, and (2) that the impact of these signals, when used
correctly, can improve people’s functioning in their own experience and the
experience of others who observe them.
While these effects are clear to the
professionals who use the LENS, it remains the job for controlled, double-blind,
randomized studies to demonstrate these effects to others. It also remains for
basic research to describe the mechanisms that allow these effects to take
place, as well as the variables which minimize and maximize the effects.
Improved functioning has been observed for those patients receiving the LENS
treatment who had plateaued in their recovery from motor paralysis and
CNS-mediated cognitive and mood impairment after mechanical and psychological
trauma. Reported improvements have persisted since data collection was begun in
1994 (and even earlier with antecedent systems).
Improvement has been reported in most of subjects (N=2500, in approximately
90,000 sessions, as of 2005) who have been treated with the LENS. When the
subjects for this research and treatment have fallen within the areas that are
known to be particularly treatable, such as mild traumatic brain injury, fibromyalgia, and explosive autism, the success rate has reached over 80%.
The
more the patient’s history has been complicated by lifelong problems preceded by
an intergenerational history of problems in parents and grandparents, and when
the patient’s problems have been numerous and complex, it is much more
complicated to judge the efficacy of this approach; thus, the “success rate” may
drop precipitously.
|